Literature DB >> 136581

Choline in tardive dyskinesia and Huntington's disease.

K L Davis, L E Hollister, J D Barchas, P A Berger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 136581     DOI： 10.1016/0024-3205(76)90095-3

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  12 in total

1.  Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.

Authors:  V P Barkhatova; E I Kandel'; E G Demina
Journal:  Neurosci Behav Physiol       Date:  1985 Mar-Apr

2.  Choline administration to the rat increases urinary catecholamines.

Authors:  M C Scally; I H Ulus; R J Wurtman
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

3.  Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.

Authors:  C de Montigny; G Chouinard; L Annable
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

4.  Dimethylaminoethanol (deanol): effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesia.

Authors:  K L Davis; L E Hollister; A L Vento; B A Beilstein; G R Rosekind
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

5.  EEG effects of physostigmine and choline chloride in humans.

Authors:  A Pfefferbaum; K L Davis; C L Coulter; R C Mohs; J R Tinklenberg; B S Kopell
Journal:  Psychopharmacology (Berl)       Date:  1979-04-25       Impact factor: 4.530

6.  2-dimethylaminoethanol (Deanol) in Huntington's chorea.

Authors:  T A Caraceni; F Girotti; I Celano; E Parati; L Balboni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-12       Impact factor: 10.154

7.  Cerebrospinal fluid acetylcholinesterase in neuropsychiatric disorders.

Authors:  K L Davis; L E Hollister; J Livesey; P A Berger
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

8.  Cholinergic inhibition of methylphenidate-induced stereotypy: oxotremorine.

Authors:  K L Davis; L E Hollister; J Tepper
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

9.  Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion.

Authors:  K L Davis; K F Faull; L E Hollister; J D Barchas; P A Berger
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Effect of choline on central dopaminergic function in normal subjects.

Authors:  S Lal; P Etienne; J Thavundayil; N P Nair; B Collier; R Rastogi; H Guyda; G Schwartz
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.